AbbVie reports promising early results for novel obesity therapy ABBV-295
ABBV-295 produced clinically meaningful, dose-dependent weight loss over 12–13 weeks
ABBV-295 produced clinically meaningful, dose-dependent weight loss over 12–13 weeks
The innovative eyedrop targets inflammation and pain following ocular surgery
The new centre brings advanced corneal procedures pioneered in India
Suffering from acute migraine? You may soon bid adieu to the debilitating headache
Breakthrough UNITY 4D Phaco delivers up to 2X faster nucleus removal and 41% less energy into the eye
The iStent platform uses tiny surgical implants to lower eye pressure by restoring the eye’s natural fluid drainage system in patients with glaucoma
Rising demands and advancements in eye care drive growth
The new combination therapy offers a dual mechanism of action for superior intraocular pressure control
This addition strengthens Dr. Agarwals Eye Hospital's vast network of 28 hospitals across Karnataka and 220+ facilities worldwide
Subscribe To Our Newsletter & Stay Updated